Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Baumgart

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Zeitschrift Fur Gastroenterologie|June 7, 2022
[Position paper on reporting of intestinal ultrasound findings in patients with inflammatory bowel disease]Torsten Kucharzik, Raja Atreya, Oliver Bachmann, et al.
Frontiers in Immunology|September 21, 2018
Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical PhenotypeMandy Sowa, Rafał Kolenda, Daniel C Baumgart, et al.
NPJ Digital Medicine|April 15, 2025
Network analysis of extraintestinal manifestations and associated autoimmune disorders in Crohn's disease and ulcerative colitisDaniel C Baumgart, C Hing Cheng, Tian X Du, et al.
Journal of the Canadian Association of Gastroenterology|February 11, 2026
Comparing the accuracy of computed tomography enterography to balloon-assisted enteroscopy in the evaluation of small bowel Crohn's diseaseJared Cooper, Scott MacKay, Matthew Reeson, et al.
Gut|June 22, 2012
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitisPaul J Rutgeerts, Richard N Fedorak, Daan W Hommes, et al.
Scientific Reports|March 11, 2025
Relating the molecular phenotype of ulcerative colitis to the clinical courseKatelynn S Madill-Thomsen, Jeffery M Venner, Denise E Parsons, et al.
Cytotherapy|February 6, 2018
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017Rachele Ciccocioppo, Claudia C Dos Santos, Daniel C Baumgart, et al.
Digestive Diseases and Sciences|March 17, 2025
Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort StudyLisa M A van Lierop, Larissa Albino, Ryan Rosentreter, et al.
Scandinavian Journal of Gastroenterology|March 8, 2018
Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitisAxel Dignass, Ayesha Akbar, Daniel C Baumgart, et al.
Lancet (London, England)|August 2, 2016
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trialJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Zeitschrift Fur Gastroenterologie|June 7, 2022
[Position paper on reporting of intestinal ultrasound findings in patients with inflammatory bowel disease]Torsten Kucharzik, Raja Atreya, Oliver Bachmann, et al.
Frontiers in Immunology|September 21, 2018
Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical PhenotypeMandy Sowa, Rafał Kolenda, Daniel C Baumgart, et al.
NPJ Digital Medicine|April 15, 2025
Network analysis of extraintestinal manifestations and associated autoimmune disorders in Crohn's disease and ulcerative colitisDaniel C Baumgart, C Hing Cheng, Tian X Du, et al.
Journal of the Canadian Association of Gastroenterology|February 11, 2026
Comparing the accuracy of computed tomography enterography to balloon-assisted enteroscopy in the evaluation of small bowel Crohn's diseaseJared Cooper, Scott MacKay, Matthew Reeson, et al.
Gut|June 22, 2012
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitisPaul J Rutgeerts, Richard N Fedorak, Daan W Hommes, et al.
Scientific Reports|March 11, 2025
Relating the molecular phenotype of ulcerative colitis to the clinical courseKatelynn S Madill-Thomsen, Jeffery M Venner, Denise E Parsons, et al.
Cytotherapy|February 6, 2018
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017Rachele Ciccocioppo, Claudia C Dos Santos, Daniel C Baumgart, et al.
Digestive Diseases and Sciences|March 17, 2025
Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort StudyLisa M A van Lierop, Larissa Albino, Ryan Rosentreter, et al.
Scandinavian Journal of Gastroenterology|March 8, 2018
Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitisAxel Dignass, Ayesha Akbar, Daniel C Baumgart, et al.
Lancet (London, England)|August 2, 2016
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trialJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
Pageof 13